The Benefit of Her-2 Targeted Therapies on Overall Survival of Patients With Metastatic Breast Cancer – A Systematic Review
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2197
https://www.valueinhealthjournal.com/article/S1098-3015(14)04127-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1657
First Page :
A620
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04127-8&doi=10.1016/j.jval.2014.08.2197